Washington, DC 20006-5349
HELPLINE
Here is a very interesting article about the man behind Alimta, the first FDA approved drug for mesothelioma treatment. “His find became tumors’ nemesis” This…
As the news of the New York City asbestos inspector continues to astonish and outrage most of us, the implications and the outstanding questions regarding…
Mesothelioma patients and their families are particularly vulnerable to ill-meaning “medicine salesmen”, such as the ones portrayed in this special investigation by 60 Minutes. Take…
In the Sunday Times dated April 11th there were some very thought provoking responses to the article we posted last week regarding palliative care. I…
As the time for the Symposium draws near we are all filled with a sense of excitement. We strive to build upon the momentum gained…
This Sunday I was struck by the New York Times article titled “Helping Patients Face Death, She Fought to Live,” about Dr. Desiree Pardi, a…
Patients often post on our bulletin board about their family members’ issues surrounding mesothelioma, which can differ greatly from the patient perspective. Though we remain…
Click here to learn more or to register for the International Symposium on Malignant Mesothelioma. [youtube=http://www.youtube.com/watch?v=AeaZWg50vKg]
Many of us donate to the Mesothelioma Foundation’s Research Grant Program and wonder ‘where do our dollars go, and does it make a difference”? Today,…
[youtube=http://www.youtube.com/watch?v=BD1q6-CC1PE]
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
